Trump’s Tweets On Drug Prices; Industry Says “Huh?”
US President targeted drug prices again on Twitter, and later in the day House Democratic Rep. Elijah Cummings announced a meeting with Trump March 8 to discuss lowering drug prices.
You may also be interested in...
Lowering the bar on drug approval standards would create a challenging environment for biotech investors, warned Jonathan Leff, a partner at the health care investment firm Deerfield, during the BIO CEO & Investor Conference.
Pharmaceutical manufacturers have been waiting for Trump’s ax to fall – and it finally did, on the final full day of the industry’s biggest business meeting of the year.
Patient enrollment in clinical trials for cancer drugs was "severely" affected by the COVID-19 pandemic, according to a report published in Nature Reviews Drug Discovery.